|
|
No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort)
Lina Mouna
,
Emilie Rossignol
,
Mariagrazia Tateo
,
Jean-Charles Duclos-Vallee
,
Christophe Duvoux
et al.
Hepatology, 2017, 66, pp.873A-874A
Journal articles
hal-01769634v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts
Isabelle Ollivier-Hourmand
,
Yohann Repesse
,
Pierre Nahon
,
Cendrine Chaffaut
,
Thông Dao
et al.
Journal articles
hal-03553907v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study
Sébastien Dharancy
,
Audrey Coilly
,
Claire Fougerou-Leurent
,
Christophe Duvoux
,
Nassim Kamar
et al.
Journal articles
hal-01640061v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment a prospective cohort study
Fabrice Carrat
,
Hélène Fontaine
,
Céline Dorival
,
Mélanie Simony
,
Alpha Diallo
et al.
Journal articles
hal-02050395v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference
Lina Mouna
,
Emilie Rossignol
,
Mariagrazia Tateo
,
Audrey Coilly
,
Jean-Charles Duclos-Vallee
et al.
Journal articles
hal-02120675v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study
Audrey Coilly
,
Claire Fougerou-Leurent
,
Victor De Ledinghen
,
Pauline Houssel-Debry
,
Christophe Duvoux
et al.
Journal articles
hal-01395132v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
EFFICACY AND SAFETY OF TREATMENT WITH BULEVIRTIDE IN CHRONIC HEPATITIS DELTA: PRELIMINARY RESULTS OF THE REAL LIFE ANRS HD EP01 BULEDELTA COHORT
Fabien Zoulim
,
Claire Fougerou
,
Roulot Marullo Dominique
,
Sophie Metivier
,
Victor de Ledinghen
et al.
Hepatology, 2022, 76 (Supp 1), pp.S221-S223
Journal articles
hal-03922586v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values results from the ANRS CO23 CUPILT cohort
Aurélie Barrail-Tran
,
Lauriane Goldwirt
,
Thibaut Gelé
,
Claire Laforest
,
Audrey Lavenu
et al.
Journal articles
hal-02280498v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy of Sofosbuvir and Daclatasvir in Patients with Fibrosing Cholestatic Hepatitis C After Liver Transplantation
Vincent Leroy
,
Jérôme Dumortier
,
Audrey Coilly
,
Mylène Sebagh
,
Claire Fougerou-Leurent
et al.
Journal articles
hal-01162384v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.
Paul Calès
,
Philippe Halfon
,
Dominique Batisse
,
Fabrice Carrat
,
Philippe Perré
et al.
Journal articles
istex
hal-00665946v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Daclatasvir plus sofosbuvir with or without ribavirin in genotype 3 patients from a large French multicenter compassionate use program
Christophe Hézode
,
Victor De Ledinghen
,
Hélène Fontaine
,
Fabien Zoulim
,
Pascal Lebray
et al.
Journal articles
hal-01380169v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Personalized surveillance for hepatocellular carcinoma in cirrhosis – using machine learning adapted to HCV status
Etienne Audureau
,
Fabrice Carrat
,
Richard Layese
,
Carole Cagnot
,
Tarik Asselah
et al.
Journal articles
hal-03284519v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.
Pauline Houssel-Debry
,
Audrey Coilly
,
Claire Fougerou-Leurent
,
Caroline Jezequel
,
Christophe Duvoux
et al.
Hepatology, 2017, 63 (1 SUPP), pp.465A--465A
Journal articles
hal-01412958v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation
Pauline Houssel-Debry
,
Audrey Coilly
,
Claire Fougerou-Leurent
,
Caroline Jezequel
,
Christophe Duvoux
et al.
Journal articles
hal-01807755v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|